International Consortium on Anti-Virals / Consortium International sur les Thérapies Antivirales

En Français • Media • Contact • Home

International Consortium on Anti-Virals (Logo)

World Health through Science / Science sans Frontières

Break
OurTrent Editor's Note:
This is a cached copy.
The original document should be available
>> here <<.

Combating Global Pandemics

A Public Symposium hosted by the International Consortium on Anti-Virals (ICAV). September 23rd 2005, 9:00 am – 6:30 pm, Gzowski College, Symons Campus, Trent University, Peterborough, Ontario, Canada.

Break
Gzowski College, Symons Campus, Trent University

Gzowski College, Symons Campus, Trent University

Break

The threat of viral pandemics continues to menace our world, as the speed and impact of the 2003 SARS outbreak made frighteningly clear. Experts agree that is not a question of if a pandemic will strike, only when and where it will first emerge. The ensuing devastation will impact every corner of the world.

Canada’s current influenza pandemic preparedness strategy is mainly based on vaccine development and stockpiling the anti-viral drug Tamiflu®. Resistant forms of the virus are bound to emerge under the selective pressure of widespread Tamiflu® use and new vaccine development will require at least 6 months. New anti-virals are therefore desperately needed to avert the potential social and economic disruption that would otherwise accompany an influenza pandemic.

Approximately 130 scientists and government representatives from 15 countries are expected to attend this Symposium which launches a two-day Workshop – Combating Global Viral Pandemics.

Break
Coronavirus Illustration

ICAV’s Fall Symposium at Trent University in Peterborough, Ontario brings together scientists, researchers, medical experts and government representatives from around the world.

Break

ICAV is a made-in-Canada initiative, founded in 2004 as a Canadian response to the SARS crisis. ICAV participants include Pasteur Institute (Paris, Shanghai, Hong Kong); Glycobiology Institute (Oxford University, Oxford); Médecins sans Frontières (Paris); Taiwan Institute of Biochemistry; Scripps Institute for Medical Research (San Diego); and the Glycomics Institute, Griffiths University (Australia) amongst others. This international team has come together to share expertise and resources with the common goal of discovering and developing new therapeutics to target viral diseases.

Welcoming Remarks

Roberta Bondar, Trent University, Ontario, Canada

Keynote Speaker

Albert Osterhaus, Erasmus Medical Center, Rotterdam, The Netherlands

Featured Speakers

  • Daniel A. Sharp, The Royal Institution World Science Assembly, US
  • Daniel Berman, Access to Essential Medicines Initiative, Médecins sans Frontières, France
  • Jean-Michel Lavoie, Pharmaciens sans Frontières, Canada
  • Anand Mehta, Drexel Institute Hepatitis B Foundation, US
  • Tom Phillips, University College of the Cayman Islands
  • Iain Gillespie, Organization for Economic Co-operation and Development, France
  • Jean-Pierre Saintouil, Institut Pasteur, France
  • Jeremy Carver, ICAV, Trent University, Canada
  • Michel Chrétien, ICAV, Ottawa Health Research Institute, Canada
  • Takeshi Kurata, National Institute of Infectious Diseases, Japan
  • Frank (Wenjun) Liu, Chinese Academy of Sciences, Beijing, China
  • Dr. Oyewale Tomori, Biovaccines Nigeria Ltd., Redeemer's University, Nigeria
  • Dr. Andrew H.-J. Wang, Institute of Biological Chemistry, Academia Sinica, Taiwan
  • Frank Plummer, National Microbiology Laboratory, Public Health Agency of Canada, Manitoba, Canada

To register or for information: submit your name by email to ICAV@shaw.ca We also invite you to be our guest at a Reception following the meeting.